UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients

International Journal of Obesity, 1999-06, Vol.23 (6), p.612-618

1999

Volltextzugriff (PDF)

Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome

The journal of clinical endocrinology and metabolism, 1997-08, Vol.82 (8), p.2439-2444

1997

Volltextzugriff (PDF)

Interaction between glucagon and hexarelin, a peptidyl GH secretagogue, on somatotroph and corticotroph secretion in humans

European journal of endocrinology, 2000-11, Vol.143 (5), p.601-606

2000

Volltextzugriff (PDF)

Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans

The journal of clinical endocrinology and metabolism, 1999, Vol.84 (1), p.285-290

1999

Volltextzugriff (PDF)

GH/IGF-I axis in anorexia nervosa

Eating and weight disorders, 2002-06, Vol.7 (2), p.94-105

2002

Volltextzugriff (PDF)

Adrenocorticotropin and cortisol hyperresponsiveness to Hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma

The journal of clinical endocrinology and metabolism, 1998-12, Vol.83 (12), p.4207-4211

1998

Volltextzugriff (PDF)

The GH, prolactin, ACTH and cortisol responses to Hexarelin, a synthetic hexapeptide, undergo different age-related variations

European journal of endocrinology, 1997-12, Vol.137 (6), p.635-642

1997

Volltextzugriff (PDF)

Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP but blunts the cortisol response to ACTH in humans

Journal of endocrinological investigation, 2002-05, Vol.25 (5), p.420-425

2002

Volltextzugriff (PDF)

Suppression and recovery of LH secretion by a potent and selective GnRH-receptor antagonist peptide in healthy early follicular-phase women are mediated via selective control of LH secretory burst mass

Clinical endocrinology (Oxford), 2003-10, Vol.59 (4), p.526-532

2003

Volltextzugriff (PDF)

Effect of galanin on basal and stimulated secretion of prolactin, gonadotropins, thyrotropin, adrenocorticotropin and cortisol in humans

European journal of endocrinology, 1995-09, Vol.133 (3), p.300-304

1995

Volltextzugriff (PDF)

Dehydroepiandrosterone sulfate levels in women. Relationships with age, body mass index and insulin levels

Journal of endocrinological investigation, 1999-10, Vol.22 (9), p.681-687

1999

Volltextzugriff (PDF)

Recombinant human IGF-I does not modify the ACTH and cortisol responses to hCRH and hexarelin, a peptidyl GH secretagogue, in humans

Journal of endocrinological investigation, 2001-02, Vol.24 (2), p.67-71

2001

Volltextzugriff (PDF)

Effects of the combined administration of hexarelin, a synthetic peptidyl GH secretagogue, and hCRH on ACTH, cortisol and GH secretion in patients with Cushing's disease

Journal of endocrinological investigation, 1999, Vol.22 (1), p.23-28

1999

Volltextzugriff (PDF)

Free Fatty Acids Exert an Inhibitory Effect on Adrenocorticotropin and Cortisol Secretion in Humans

The journal of clinical endocrinology and metabolism, 2004-03, Vol.89 (3), p.1385-1390

2004

Volltextzugriff (PDF)

Effects of Recombinant Human Insulin-Like Growth Factor I Administration on Growth Hormone (GH) Secretion, Both Spontaneous and Stimulated by GH-Releasing Hormone or Hexarelin, a Peptidyl GH Secretagogue, in Humans1

The journal of clinical endocrinology and metabolism, 1999-01, Vol.84 (1), p.285-290

1999

Volltextzugriff (PDF)

Influence of galanin and serotonin on the endocrine response to Hexarelin, a synthetic peptidyl GH-secretagogue, in normal women

Journal of endocrinological investigation, 1998-11, Vol.21 (10), p.673-679

1998

Volltextzugriff (PDF)

Low Hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man

Clinical endocrinology (Oxford), 1997-10, Vol.47 (4), p.495-500

1997

Volltextzugriff (PDF)

Influence of beta-adrenergic agonists and antagonists on the GH-releasing effect of Hexarelin in man

Journal of endocrinological investigation, 1996, Vol.19 (1), p.25-29

1996

Volltextzugriff (PDF)

The activity of GH/IGF-I axis in anorexia nervosa and in obesity: a comparison with normal subjects and patients with hypopituitarism or critical illness

Eating and weight disorders, 1998-06, Vol.3 (2), p.64-70

1998

Volltextzugriff (PDF)

Interaction of salbutamol with pyridostigmine and arginine on both basal and GHRH-stimulated GH secretion in humans

Clinical endocrinology (Oxford), 1994-06, Vol.40 (6), p.799-802

1994

Volltextzugriff (PDF)

Effects of histaminergic antagonists on the GH-releasing activity of GHRH or hexarelin, a synthetic hexapeptide, in man

Journal of endocrinological investigation, 1997-03, Vol.20 (3), p.122-127

1997

Volltextzugriff (PDF)

Neurotransmitter control of growth hormone secretion in humans

Journal of Pediatric Endocrinology and Metabolism, 1993, Vol.6 (3-4), p.263

1993

Volltextzugriff (PDF)

Young adults with Down's syndrome show increased corticotrope responsiveness to hCRH or hexarelin, a peptidyl GH secretagogue

Journal of endocrinological investigation, 1999, Vol.22 (10), p.57-58

1999

Volltextzugriff (PDF)

The enhancing effect of pyridostigmine on the GH response to GHRH undergoes an accelerated age-related reduction in Down syndrome

Dementia (Basel, Switzerland), 1996-09, Vol.7 (5), p.288-292

1996

Volltextzugriff (PDF)

Une histoire du traitement du signal

Traitement du signal, 1989, Vol.6 (3), p.151-152

1989

Volltextzugriff (PDF)

1 – 25 von 134

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(108)

Publikationsform

Artikel
(108)
Reviews
(23)
Buchkapitel
(1)
Berichte
(1)
Texte
(1)

Sprache

Englisch
(70)
Französisch
(65)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients

Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome

Interaction between glucagon and hexarelin, a peptidyl GH secretagogue, on somatotroph and corticotroph secretion in humans

Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans

GH/IGF-I axis in anorexia nervosa

Adrenocorticotropin and cortisol hyperresponsiveness to Hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma

The GH, prolactin, ACTH and cortisol responses to Hexarelin, a synthetic hexapeptide, undergo different age-related variations

Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP but blunts the cortisol response to ACTH in humans

Suppression and recovery of LH secretion by a potent and selective GnRH-receptor antagonist peptide in healthy early follicular-phase women are mediated via selective control of LH secretory burst mass

Effect of galanin on basal and stimulated secretion of prolactin, gonadotropins, thyrotropin, adrenocorticotropin and cortisol in humans

Dehydroepiandrosterone sulfate levels in women. Relationships with age, body mass index and insulin levels

Recombinant human IGF-I does not modify the ACTH and cortisol responses to hCRH and hexarelin, a peptidyl GH secretagogue, in humans

Effects of the combined administration of hexarelin, a synthetic peptidyl GH secretagogue, and hCRH on ACTH, cortisol and GH secretion in patients with Cushing's disease

Free Fatty Acids Exert an Inhibitory Effect on Adrenocorticotropin and Cortisol Secretion in Humans

Effects of Recombinant Human Insulin-Like Growth Factor I Administration on Growth Hormone (GH) Secretion, Both Spontaneous and Stimulated by GH-Releasing Hormone or Hexarelin, a Peptidyl GH Secretagogue, in Humans1

Influence of galanin and serotonin on the endocrine response to Hexarelin, a synthetic peptidyl GH-secretagogue, in normal women

Low Hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man

Influence of beta-adrenergic agonists and antagonists on the GH-releasing effect of Hexarelin in man

The activity of GH/IGF-I axis in anorexia nervosa and in obesity: a comparison with normal subjects and patients with hypopituitarism or critical illness

Interaction of salbutamol with pyridostigmine and arginine on both basal and GHRH-stimulated GH secretion in humans

Effects of histaminergic antagonists on the GH-releasing activity of GHRH or hexarelin, a synthetic hexapeptide, in man

Neurotransmitter control of growth hormone secretion in humans

Young adults with Down's syndrome show increased corticotrope responsiveness to hCRH or hexarelin, a peptidyl GH secretagogue

The enhancing effect of pyridostigmine on the GH response to GHRH undergoes an accelerated age-related reduction in Down syndrome

Une histoire du traitement du signal

Suchergebnisse filtern